Cost-Effectiveness Analysis of Obeticholic Acid For The Treatment of Primary Biliary Cholangitis (PBC) Patients With Inadequate Response or Intolerance To Ursodeoxycholic Acid (UDCA) In France
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.895
https://www.valueinhealthjournal.com/article/S1098-3015(17)31229-9/fulltext
Title :
Cost-Effectiveness Analysis of Obeticholic Acid For The Treatment of Primary Biliary Cholangitis (PBC) Patients With Inadequate Response or Intolerance To Ursodeoxycholic Acid (UDCA) In France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31229-9&doi=10.1016/j.jval.2017.08.895
First page :
A556
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
854